Skip to main content
Aller à la page d’accueil de la Commission européenne (s’ouvre dans une nouvelle fenêtre)
français fr
CORDIS - Résultats de la recherche de l’UE
CORDIS
Contenu archivé le 2024-05-14

Mammalian cloning in Europe: prospects and public policy

Objectif



This study is designed to provide an assessment of mammalian cloning technology, its possible risks and benefits, and how public policy might help steer its development in a manner which is both socially acceptable and economically useful.
The creation of the first cloned mammal, 'Dolly' the sheep, has been seen as a landmark, demonstrating both the power of science and the scale of public fears surrounding genetic engineering. This technical achievement has provoked controversy and stimulated major public policy debates in many countries, with the emphasis on the ethics of cloning humans. However, fear of human cloning has overshadowed the longer-term significance of this research, as it is in the field of animal biotechnology and in the development of new medical technologies that cloning could provide major benefits.
Public policy makers are therefore faced with a dilemma in balancing the need to maintain public confidence in biotechnology, by guaranteeing that research on cloning is ethical and socially acceptable, whilst at the same time ensuring that regulation will not inhibit its industrial exploitation.
The objectives of the study are therefore to:
1. Assess the scientific significance of the cloning of mammals and identify both short and long-term potential applications of the technique; 2. Make a comparative analysis of the public perception of mammalian cloning, the ethical problems raised, and the public policy response to these issues, in the UK and the Netherlands;
3. Analyse the relative success of different national approaches to mammalian cloning and suggest how public policy might be best used to socially manage the technology in Europe.
To meet these objectives the work programme will be composed of the following activities:
- A detailed literature review of research on mammalian cloning - Interviews with leading scientists and companies working on mammalian cloning.
- A short survey of European biotechnology firms working in fields related to cloning
- Detailed case studies of the public debate and regulation of cloning in the UK and Netherlands
The project will conclude by making an informed assessment of 1. the prospects, near-term applications and potential benefits of cloning; 2. the key ethical and social issues these developments are likely to raise; and 3. the strengths and weaknesses of different public policy approaches to this issue. Recommendations will be made for how policy in Europe might be improved to ensure that technologies based on mammalian cloning techniques might be effectively developed in a socially acceptable manner.

Champ scientifique (EuroSciVoc)

CORDIS classe les projets avec EuroSciVoc, une taxonomie multilingue des domaines scientifiques, grâce à un processus semi-automatique basé sur des techniques TLN. Voir: Le vocabulaire scientifique européen.

Vous devez vous identifier ou vous inscrire pour utiliser cette fonction

Programme(s)

Programmes de financement pluriannuels qui définissent les priorités de l’UE en matière de recherche et d’innovation.

Thème(s)

Les appels à propositions sont divisés en thèmes. Un thème définit un sujet ou un domaine spécifique dans le cadre duquel les candidats peuvent soumettre des propositions. La description d’un thème comprend sa portée spécifique et l’impact attendu du projet financé.

Appel à propositions

Procédure par laquelle les candidats sont invités à soumettre des propositions de projet en vue de bénéficier d’un financement de l’UE.

Données non disponibles

Régime de financement

Régime de financement (ou «type d’action») à l’intérieur d’un programme présentant des caractéristiques communes. Le régime de financement précise le champ d’application de ce qui est financé, le taux de remboursement, les critères d’évaluation spécifiques pour bénéficier du financement et les formes simplifiées de couverture des coûts, telles que les montants forfaitaires.

CSC - Cost-sharing contracts

Coordinateur

UNIVERSITY OF SUSSEX
Contribution de l’UE
Aucune donnée
Coût total

Les coûts totaux encourus par l’organisation concernée pour participer au projet, y compris les coûts directs et indirects. Ce montant est un sous-ensemble du budget global du projet.

Aucune donnée

Participants (1)

Mon livret 0 0